Inactivation of the Moloney Murine Leukemia Virus Long Terminal Repeat in Murine Fibroblast Cell Lines is Associated with Methylation and Dependent on Its Chromosomal Position

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1991 Feb 1

PMID 1702844

Citations 39

Authors

R C Hoeben

A A Migchielsen

R C van der Jagt

H Van Ormondt

A J Van Der Eb

Affiliations

Soon will be listed here.

Abstract

The expression of a retroviral vector with the Moloney murine leukemia virus (Mo-MuLV) long terminal repeat (LTR) promoter after integration into the genome of murine fibroblast cell lines was monitored with the Escherichia coli-derived beta-galactosidase (beta-gal) gene as the reporter. Monoclonal cell lines derived after retroviral infection exhibited a marked heterogeneity in their expression of the reporter gene. We studied two monoclonal cell lines with a single unrearranged copy of the vector provirus integrated into their genome. The first, BB10, expressed the marker enzyme in only 8% of its cell population, whereas in the second, BB16, beta-gal expression could be detected in over 98% of the cells. Treatment of BB10 with the DNA-demethylating agent 5-azacytidine raised the number of beta-gal-positive cells to over 60%. Transfection experiments showed that the Mo-MuLV LTR promoter-enhancer is potentially fully functional in both the BB10 and BB16 cell lines. The inactivated provirus from BB10 cells was cloned and subsequently used to generate retrovirus stocks. The promoter-enhancer activity of its LTR after infection with these BB10-derived viruses showed a variation similar to that of the original virus stocks. Our data showed that (1) inactivation of the Mo-MuLV LTR is a frequent event in murine fibroblast cell lines, (2) inactivation is associated with de novo methylation of cytidine residues, (3) the frequency of inactivation of the provirus must be determined by its chromosomal position, (4) the process of methylation of sequences within the LTR is not necessarily the same as the transcription-repression mechanism that is operating in undifferentiated embryonal carcinoma cells.

Citing Articles

Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy.

Suerth J, Labenski V, Schambach A Viruses. 2014; 6(12):4811-38.

PMID: 25490763 PMC: 4276931. DOI: 10.3390/v6124811.

Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening.

Shah P, Walker M, Sims C, Major M, Allbritton N Integr Biol (Camb). 2014; 6(7):673-84.

PMID: 24871928 PMC: 4098877. DOI: 10.1039/c4ib00050a.

Epigenetic changes of lentiviral transgenes in porcine stem cells derived from embryonic origin.

Choi K, Park J, Kim H, Uh K, Son D, Lee C PLoS One. 2013; 8(8):e72184.

PMID: 23977247 PMC: 3747048. DOI: 10.1371/journal.pone.0072184.

Reactivation of Silenced WT1 Transgene by Hypomethylating Agents - Implications for in vitro Modeling of Chemoimmunotherapy.

Kwon Y, Son M, Kim H, Kim Y Immune Netw. 2012; 12(2):58-65.

PMID: 22740791 PMC: 3382665. DOI: 10.4110/in.2012.12.2.58.

Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning.

Huston M, van Til N, Visser T, Arshad S, Brugman M, Cattoglio C Mol Ther. 2011; 19(10):1867-77.

PMID: 21750532 PMC: 3188737. DOI: 10.1038/mt.2011.127.

References

Guild B, Finer M, Housman D, Mulligan R . Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. J Virol. 1988; 62(10):3795-801. PMC: 253524. DOI: 10.1128/JVI.62.10.3795-3801.1988. View

Loh T, Sievert L, Scott R . Proviral sequences that restrict retroviral expression in mouse embryonal carcinoma cells. Mol Cell Biol. 1987; 7(10):3775-84. PMC: 368034. DOI: 10.1128/mcb.7.10.3775-3784.1987. View

Greaves D, Wilson F, Lang G, Kioussis D . Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell. 1989; 56(6):979-86. DOI: 10.1016/0092-8674(89)90631-4. View

Soriano P, Cone R, Mulligan R, Jaenisch R . Tissue-specific and ectopic expression of genes introduced into transgenic mice by retroviruses. Science. 1986; 234(4782):1409-13. DOI: 10.1126/science.3024318. View

Grosveld F, Van Assendelft G, Greaves D, Kollias G . Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell. 1987; 51(6):975-85. DOI: 10.1016/0092-8674(87)90584-8. View

Weiher H, Barklis E, Ostertag W, Jaenisch R . Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. J Virol. 1987; 61(9):2742-6. PMC: 255781. DOI: 10.1128/JVI.61.9.2742-2746.1987. View

Barklis E, Mulligan R, Jaenisch R . Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell. 1986; 47(3):391-9. DOI: 10.1016/0092-8674(86)90596-9. View

Hoeben R, van der Jagt R, Schoute F, VAN Tilburg N, Verbeet M, Briet E . Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer. J Biol Chem. 1990; 265(13):7318-23. View

Adams R . DNA methylation. The effect of minor bases on DNA-protein interactions. Biochem J. 1990; 265(2):309-20. PMC: 1136889. DOI: 10.1042/bj2650309. View

10.

Moore K, Fletcher F, Villalon D, Utter A, Belmont J . Human adenosine deaminase expression in mice. Blood. 1990; 75(10):2085-92. View

11.

Mooslehner K, Karls U, Harbers K . Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions. J Virol. 1990; 64(6):3056-8. PMC: 249491. DOI: 10.1128/JVI.64.6.3056-3058.1990. View

12.

Kaleko M, Garcia J, Osborne W, Miller A . Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow. Blood. 1990; 75(8):1733-41. View

13.

Scherdin U, Rhodes K, Breindl M . Transcriptionally active genome regions are preferred targets for retrovirus integration. J Virol. 1990; 64(2):907-12. PMC: 249188. DOI: 10.1128/JVI.64.2.907-912.1990. View

14.

Wilson J, Danos O, Grossman M, Raulet D, Mulligan R . Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci U S A. 1990; 87(1):439-43. PMC: 53279. DOI: 10.1073/pnas.87.1.439. View

15.

Linney E, Davis B, Overhauser J, Chao E, Fan H . Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells. Nature. 1984; 308(5958):470-2. DOI: 10.1038/308470a0. View

16.

Shinnick T, Lerner R, Sutcliffe J . Nucleotide sequence of Moloney murine leukaemia virus. Nature. 1981; 293(5833):543-8. DOI: 10.1038/293543a0. View

17.

Niwa O, Yokota Y, Ishida H, Sugahara T . Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells. Cell. 1983; 32(4):1105-13. DOI: 10.1016/0092-8674(83)90294-5. View

18.

Feinberg A, Vogelstein B . A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983; 132(1):6-13. DOI: 10.1016/0003-2697(83)90418-9. View

19.

Simon D, Stuhlmann H, Jahner D, Wagner H, Werner E, Jaenisch R . Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious. Nature. 1983; 304(5923):275-7. DOI: 10.1038/304275a0. View

20.

Stuhlmann H, Jahner D, Jaenisch R . Infectivity and methylation of retroviral genomes is correlated with expression in the animal. Cell. 1981; 26(2 Pt 2):221-32. DOI: 10.1016/0092-8674(81)90305-6. View